Day: June 4, 2024

TOWER CAPITAL ASIA ANNOUNCES COMPLETION OF SALE OF EU YAN SANG BY RIGHTEOUS CRANE HOLDING TO ROHTO PHARMACEUTICAL AND MITSUI AT A CONSIDERATION WHICH VALUES EU YAN SANG AT APPROXIMATELY S$808 MILLION

Tower Capital Asia (“Tower Capital Asia” or the “Firm”) is pleased to confirm the successful completion of the previously announced sale on 4 April 2024 by Righteous Crane Holding Pte. Ltd.